Eurofins · 10 hours ago
Virus Testing Associate Scientist- Entry Level
Eurofins is an international life sciences company providing a range of analytical testing services. They are seeking an entry level Associate Scientist to perform virology techniques, tissue culture, and ensure compliance with GMP standards.
BiotechnologyGeneticsHealth CareLife SciencePharmaceutical
Responsibilities
Perform aseptic tissue culture techniques such as expansion and seeding of adherent and suspension tissue culture lines, including numerous mammalian and insect culture cell lines
Perform common lab skills include microscopy, aseptic media preparation, mechanical pipetting, serial dilution preparations, and basic calculations including the use of Excel spreadsheets
Perform virology techniques including inoculation of tissue culture systems with various model viruses, plaque assays, focus assays, and other secondary techniques such as hemagglutination/hemadsorption assays and immunofluorescence staining
Review and evaluate raw data for acceptability
Set up and validate new analytical or related processes used by the department
Document work as required for GMP compliance
Qualification
Required
Bachelor's degree in biology, molecular or cell biology, or-related field or other related degree concentration
Authorization to work in the United States indefinitely without restriction or sponsorship
Excellent communication (oral and written) and attention to detail
Ability to work independently and as part of a team, self-motivation, adaptability, and a positive attitude
Ability to learn new techniques, perform multiple tasks simultaneously, keep accurate records, follow instructions, and comply with company policies
Benefits
Excellent full time benefits including comprehensive medical coverage, dental, and vision options
Life and disability insurance
401(k) with company match
Paid vacation and holidays
Company
Eurofins
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer products industries.
Funding
Current Stage
Public CompanyTotal Funding
$1.05B2025-06-26Post Ipo Debt· $586.37M
2025-03-27Post Ipo Debt· $431.4M
2021-10-22Grant· $30M
Recent News
2025-12-16
Business Wire
2025-12-08
Company data provided by crunchbase